2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2011 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2011 - Sedgwick Memorial Medal, American Public Health Association
2000 - Metlife Foundation Award for Medical Research in Alzheimer's Disease
Dennis W. Dickson focuses on Pathology, Alzheimer's disease, Dementia, Genetics and Disease. His Pathology research focuses on Progressive supranuclear palsy, Frontotemporal dementia, Neuropathology, Parkinsonism and Neurofibrillary tangle. His work investigates the relationship between Frontotemporal dementia and topics such as Amyotrophic lateral sclerosis that intersect with problems in C9orf72 Protein.
Tau protein and Neurodegeneration is closely connected to Neuroscience in his research, which is encompassed under the umbrella topic of Neuropathology. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Hippocampal sclerosis, Autopsy and Degenerative disease. His work in Dementia addresses subjects such as Psychiatry, which are connected to disciplines such as Pediatrics.
Dennis W. Dickson mainly focuses on Pathology, Disease, Dementia, Alzheimer's disease and Neuroscience. His study in Pathology focuses on Progressive supranuclear palsy, Frontotemporal lobar degeneration, Atrophy, Frontotemporal dementia and Neuropathology. His study in Progressive supranuclear palsy is interdisciplinary in nature, drawing from both Tau protein and Tauopathy.
His studies deal with areas such as Genetics and Pathological as well as Disease. His Dementia research includes themes of Hippocampal sclerosis, Pediatrics and Parkinsonism. His Alzheimer's disease research integrates issues from Apolipoprotein E and Degenerative disease.
The scientist’s investigation covers issues in Pathology, Disease, Progressive supranuclear palsy, Dementia and Neuropathology. His study in Atrophy, Frontotemporal lobar degeneration, Parkinsonism, Frontotemporal dementia and Neurofibrillary tangle are all subfields of Pathology. He focuses mostly in the field of Frontotemporal lobar degeneration, narrowing it down to topics relating to C9orf72 and, in certain cases, Neurodegeneration, RNA, Cell biology and C9orf72 Protein.
His work carried out in the field of Disease brings together such families of science as Neuroscience and Cohort. His Progressive supranuclear palsy research focuses on Tauopathy and how it connects with Tau protein. The Dementia study combines topics in areas such as Allele and Pediatrics.
His primary scientific interests are in Pathology, Disease, Progressive supranuclear palsy, Dementia and Tauopathy. His research integrates issues of Hippocampal sclerosis and Hippocampus in his study of Pathology. Particularly relevant to Alzheimer's disease is his body of work in Disease.
His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Dementia with Lewy bodies and Cognitive decline. The study incorporates disciplines such as Tau pathology, Genome-wide association study and Neuroscience in addition to Progressive supranuclear palsy. As a member of one scientific family, Dennis W. Dickson mostly works in the field of Dementia, focusing on Apolipoprotein E and, on occasion, Oncology and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop
I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry.
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
Mariely DeJesus-Hernandez;Ian R. Mackenzie;Bradley F. Boeve;Adam L. Boxer.
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Marilyn S. Albert;Steven T. DeKosky;Dennis Dickson;Bruno Dubois.
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
M. Hutton;C. L. Lendon;P. Rizzu;M. Baker.
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner.
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday.
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman;Creighton H. Phelps;Thomas G. Beach;Eileen H. Bigio.
Alzheimers & Dementia (2012)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker;Ian R. Mackenzie;Stuart M. Pickering-Brown;Jennifer Gass.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: